|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 11
Zeitschriftenartikel
Bartova, Lucie; Dold, Markus; Volz, Hans-Peter; Seifritz, Erich; Moeller, Hans-Juergen und Kasper, Siegfried
(2022):
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 273: S. 51-63
Volz, Hans-Peter; Saliger, Julia; Kasper, Siegfried; Moeller, Hans-Juergen und Seifritz, Erich
(2022):
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature survey.
In: International Journal of Psychiatry in Clinical Practice, Bd. 26, Nr. 3: S. 277-286
Seifritz, Erich; Kasper, Siegfried; Moeller, Hans-Juergen; Volz, Hans-Peter; Mueller, Walter E.; Eckert, Anne und Hatzinger, Martin
(2022):
Effect of anxiolytic drug silexan on sleep - a narrative review.
In: World Journal of Biological Psychiatry, Bd. 23, Nr. 7: S. 493-500
Bandelow, Borwin; Allgulander, Christer; Baldwin, David S.; da Conceicao Costa, Daniel Lucas; Denys, Damiaan; Dilbaz, Nesrin; Domschke, Katharina; Hollander, Eric; Kasper, Siegfried; Moeller, Hans-Juergen; Eriksson, Elias; Fineberg, Naomi A.; Haettenschwiler, Josef; Kaiya, Hisanobu; Karavaeva, Tatiana; Katzman, Martin A.; Kim, Yong-Ku; Inoue, Takeshi; Lim, Leslie; Masdrakis, Vasilios; Menchon, Jose M.; Miguel, Euripedes C.; Nardi, Antonio E.; Pallanti, Stefano; Perna, Giampaolo; Rujescu, Dan; Starcevic, Vladan; Stein, Dan J.; Tsai, Shih-Jen; Ameringen, Michael van; Vasileva, Anna; Wang, Zhen und Zohar, Joseph
(2022):
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.
In: World Journal of Biological Psychiatry, Bd. 24, Nr. 2: S. 118-134
Fountoulakis, Konstantinos N.; Veroniki, Areti Angeliki; Siamouli, Melina und Moeller, Hans-Juergen
(2013):
No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.
In: Annals of General Psychiatry
12:26
[PDF, 239kB]
Schaub, Annette; Neubauer, Nicole; Mueser, Kim T.; Engel, Rolf und Moeller, Hans-Juergen
(2013):
Neuropsychological functioning in inpatients with major depression or schizophrenia.
In: BMC Psychiatry
13:203
[PDF, 173kB]
Fountoulakis, Konstantinos N.; Hoschl, Cyril; Kasper, Siegfried; Lopez-Ibor, Juan und Moeller, Hans-Juergen
(2013):
The media and intellectuals' response to medical publications: the antidepressants' case.
In: Annals of General Psychiatry
12:11
[PDF, 3MB]
Seemueller, Florian; Moeller, Hans-Juergen; Dittmann, Sandra und Musil, Richard
(2012):
Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
In: BMC Medicine
10:17
[PDF, 157kB]
Obermeier, Michael; Schennach-Wolff, Rebecca; Meyer, Sebastian; Moeller, Hans-Juergen; Riedel, Michael; Krause, Daniela und Seemueller, Florian
(2011):
Is the PANSS used correctly? a systematic review.
In: BMC Psychiatry
11:113
[PDF, 186kB]
Need, Anna C.; Ge, Dongliang; Weale, Michael E.; Maia, Jessica; Feng, Sheng; Heinzen, Erin L.; Shianna, Kevin V.; Yoon, Woohyun; Kasperaviciute, Dalia; Gennarelli, Massimo; Strittmatter, Warren J.; Bonvicini, Cristian; Rossi, Giuseppe; Jayathilake, Karu; Cola, Philip A.; McEvoy, Joseph P.; Keefe, Richard S. E.; Fisher, Elizabeth M. C.; St. Jean, Pamela L.; Giegling, Ina; Hartmann, Annette M.; Moeller, Hans-Juergen; Ruppert, Andreas; Fraser, Gillian; Crombie, Caroline; Middleton, Lefkos T.; St. Clair, David; Roses, Allen D.; Muglia, Pierandrea; Francks, Clyde; Rujescu, Dan; Meltzer, Herbert Y. und Goldstein, David B.
(Februar 2009):
A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia.
In: PLOS Genetics 5(2), e1000373 [PDF, 392kB]
In: PLOS Genetics 5(2), e1000373 [PDF, 392kB]
Treur, Maarten; Heeg, Bart; Moeller, Hans-Juergen; Schmeding, Annette und van Hout, Ben
(2009):
A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.
In: BMC Health Services Research
9:32
[PDF, 257kB]